NDC 55154-8713
Myrbetriq 50 mg tablet, film coated, extended release
On the label: Cardinal Health 107, LLC. It's repackaged: Cardinal Health 107, LLC rebottles it from Astellas Pharma US, Inc.'s NDC 0469-2602.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Astellas Ireland Co., Limited | Dublin, Ireland | Makes the active ingredient and tests it | Problems found, fixed voluntarilyJun 17, 2022 · 4 inspections |
| Astellas Pharma Inc. | Takahagi, Japan | Makes the active ingredient and tests it | Problems found, fixed voluntarilyJun 6, 2025 · 4 inspections |
| Sumitomo Chemical Company, Limited | Kurashiki, Japan | Makes the active ingredient | No problems foundNov 2, 2023 · 3 inspections |
Product details
- Generic drug
- Mirabegron: every company that makes it
- Form
- tablet, film coated, extended release
- Strength
- 50 mg
- Approval
- NDA NDA202611
- On the market since
- Jun 28, 2012
- Package NDCs
55154-8713-8- Official label
- DailyMed (National Library of Medicine), updated Sep 26, 2024
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?